| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/25/2005 | CA2068224C Novel potent inducers of terminal differentiation and method of use thereof |
| 01/20/2005 | WO2005005606A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/20/2005 | WO2005005456A2 Peptide deformylase inhibitors |
| 01/20/2005 | WO2005005397A1 5-substituted quinazolinone derivatives |
| 01/20/2005 | WO2005005396A1 Process of making di-aryl urea compounds |
| 01/20/2005 | WO2005005395A2 Arylamine-substituted quinazolinone compounds |
| 01/20/2005 | WO2005005394A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/20/2005 | WO2005005380A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | WO2004073601A3 Process for the preparation of hexacyclic camptothecin derivatives |
| 01/20/2005 | WO2004066905A3 Process for preparation of 2-alkoxy-6-(trifluoromethyl)pyrimidin-4-ol |
| 01/20/2005 | WO2004058787A3 Fluorogenic enzyme substrates and methods of preparation |
| 01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |
| 01/20/2005 | US20050014916 Ruthenium complexes, process for preparation thereof, and processes for producing open-ring polymer of cycloolefins and hydrogenation products thereof by using the complex as catalyst |
| 01/20/2005 | US20050014774 Oxo-pyrimidine compounds |
| 01/20/2005 | US20050014772 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 01/20/2005 | US20050014769 Anticancer agents; controlling apoptosis |
| 01/20/2005 | US20050014753 Antitumor agents |
| 01/20/2005 | US20050014746 compounds which bind to the interaction-domain (I-domain) of LFA-1, thus interrupting endothelial cell-leukocyte adhesion by blocking the interaction of LFA-1 with ICAM-1, ICAM-3, and other adhesion molecules |
| 01/20/2005 | CA2530776A1 Process of making di-aryl urea compounds |
| 01/20/2005 | CA2530538A1 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/20/2005 | CA2530450A1 5-substituted quinazolinone derivatives |
| 01/20/2005 | CA2530312A1 Arylamine-substituted quinazolinone compounds |
| 01/20/2005 | CA2530182A1 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/20/2005 | CA2530025A1 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2005 | EP1497672A2 Ultrasonic doppler effect speed measurement |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1287018B1 Thrombin inhibitors |
| 01/19/2005 | EP1181271B1 Naphthalene ureas as glucose uptake enhancers |
| 01/19/2005 | EP0777492B1 Combinatorial libraries of substrate-bound cyclic organic compounds |
| 01/19/2005 | CN1568370A Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| 01/19/2005 | CN1568315A Process for the preparation of 1-(pyrimidin-2-yl) propan-2-ones |
| 01/19/2005 | CN1568185A Compounds effecting glucokinase |
| 01/19/2005 | CN1566102A Minoxidilum sulfate and preparation method thereof |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1185217C Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 01/19/2005 | CN1185216C Fungicides |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/19/2005 | CN1185108C Heat sensitive recording material |
| 01/18/2005 | US6844437 Chemical intermediates; anticholesterol agents, antilipemic agents |
| 01/18/2005 | US6844436 Chlorosulfonation, cyclization, salt formation'; impotency; cardiovascular disorders; antidiabetic agents; central nervous system disorders |
| 01/18/2005 | US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 01/18/2005 | US6844343 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 01/18/2005 | US6844032 Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices |
| 01/13/2005 | WO2005003103A2 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases |
| 01/13/2005 | WO2005003100A2 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| 01/13/2005 | WO2005003099A2 Pyrimidines useful as modulators of voltage-gated ion channels |
| 01/13/2005 | WO2005003098A1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 01/13/2005 | WO2005002582A2 Trp-p8 active compounds and therapeutic treatment methods |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009842 2-hydroxymethylcyclopropylidene methylpurines and -pyrimidines as antiviral agents |
| 01/13/2005 | US20050009817 Substituted heteroaryls |
| 01/13/2005 | DE10328479A1 6-Arylamino-5-cyano-4-pyrimidinone 6-arylamino-5-cyano-4-pyrimidinones |
| 01/13/2005 | DE10328400A1 One-pot synthesis of carbocyclic or heterocyclic compounds, especially pyrimidine useful as components of natural products or drugs, from acid halide, alkyne and active hydrogen compound |
| 01/13/2005 | DE10328173A1 Triazolopyrimidine Triazolopyrimidines |
| 01/13/2005 | CA2531327A1 Compounds and therapeutical use thereof |
| 01/13/2005 | CA2531061A1 Pyrimidines useful as modulators of voltage-gated ion channels |
| 01/13/2005 | CA2531060A1 Heterocyclically-substitued pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 01/13/2005 | CA2530884A1 Trp-p8 active compounds and therapeutic treatment methods |
| 01/12/2005 | EP1495006A1 Inhibitors of glycinamide ribonucleotide transformylase |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494672A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity |
| 01/12/2005 | EP1228043B1 Isoquinoline and quinazoline deivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 01/12/2005 | EP0930286B1 Liquid-crystal alkenyltolan derivative, liquid-crystal composition, and liquid-crystal display element |
| 01/12/2005 | CN1563006A Synthesizing nucleoside analog for antivirus |
| 01/12/2005 | CN1562978A Compound of multiple substituted uracil class, preparation method and usage |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841672 Method for producing 4-methyl pyrimidine |
| 01/11/2005 | US6841554 Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 01/11/2005 | US6841553 Contorlling fertility |
| 01/06/2005 | WO2005000822A1 N-{‘4-substituted piperazine-1-sulfonylmethyl!alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/06/2005 | WO2005000406A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | WO2005000404A2 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 01/06/2005 | WO2004103977A3 Process for the preparation of pyrimidine derivatives |
| 01/06/2005 | WO2004037166A3 Therapeutic guanidines |
| 01/06/2005 | US20050004151 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators |
| 01/06/2005 | US20050004148 Human immunodeficiency and hepatitis B infections; high activity, low toxicity |
| 01/06/2005 | US20050004143 Bi-cyclic pyrimidine inhibitors of TGFbeta |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004125 Such as 4-[[4-(1-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]-benzonitrile; bipolar disorder, pain, type 2 diabetes |
| 01/06/2005 | US20050004123 Substituted aryl sulphonyl(thio)ureas used as herbicides |
| 01/06/2005 | US20050004117 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 01/06/2005 | US20050004111 Degenerative joints disease; osteoarthritis |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050003230 cyclized; organic light-emitting diodes (OLED); eliminate drawbacks of Alq3 as emitter and a host material for dopants; narrower emission bands; broad spectral range; low driver voltages; high photometric efficiency (low power consumption); high luminance (emission intensity); high thermal stability |
| 01/06/2005 | CA2556706A1 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | CA2530378A1 Pyrazolopyrimidines |
| 01/06/2005 | CA2529468A1 N-{[4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/06/2005 | CA2527079A1 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 01/06/2005 | CA2526487A1 Heterocyclic methyl sulfone derivative |
| 01/05/2005 | EP1493735A1 Pyrimidine derivatives useful as selective cox-2 inhibitors |
| 01/05/2005 | EP1493733A2 Fungicidal heterocyclic aromatic amides, their compositions and methods of use |
| 01/05/2005 | EP1493432A1 In vivo method of obtaining cell components |
| 01/05/2005 | EP1492775A2 Oxo-azabicyclic compounds |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives |